Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (5)
Cancer Screening and Survivorship (4)
Cell Therapy (5)
Clinical Trials (2)
Gastrointestinal Cancer (4)
Genitourinary Cancer (5)
Gynecologic Oncology (4)
Head and Neck Cancer (5)
Hematologic Oncology (5)
Immunotherapy (4)
Neuro-Oncology (3)
Pediatric Hematology/Oncology (3)
Primary Care (4)
Radiation Oncology (4)
Skin Cancer (16)
Surgical Oncology (1)
Thoracic Cancer (4)
Young Adult Malignancies (2)

Types

News (11)
Video Asset (5)

Showing 1 - 12 of 16 results

Previous| 1 | 2 |Next

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

Meet the Team: Ankit Patel, MD

Meet the Team: Ankit Patel, MD

Roswell Park is Hiring!

Roswell Park is Hiring!

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma

Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma

Meet the Team: Cerrene Giordano, MD

Meet the Team: Cerrene Giordano, MD

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

Clinical Trial Evaluates Smaller Surgical Margins for Stage 2 Melanoma Patients

Clinical Trial Evaluates Smaller Surgical Margins for Stage 2 Melanoma Patients

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Showing 1 - 12 of 16 results

Previous| 1 | 2 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer